Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimal Precision TherapIes to CustoMISE Care in Childhood and Adolescent Cancer

NCT06208657 is registered in ClinicalTrials.gov with Australian & New Zealand Children's Haematology/Oncology Group as lead sponsor.

NCT NCT06208657
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06208657 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimal Precision TherapIes to CustoMISE Care in Childhood and Adolescent Cancer
Lead sponsor
Australian & New Zealand Children's Haematology/Oncology Group
Phase
Phase 1/2
Overall status
Recruiting
Start date
July 10, 2024
Completion date
December 31, 2035
Enrollment
90 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

childhood brain tumor, childhood cancer, childhood solid tumor, recurrent cancer, refractory cancer